Structural insights into G domain dimerization and pathogenic mutation of OPA1.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
06 07 2020
Historique:
received: 15 07 2019
revised: 18 02 2020
accepted: 19 04 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 18 3 2021
Statut: ppublish

Résumé

The fusion of mammalian inner mitochondrial membranes (IMMs) is mediated by dynamin-like GTPase OPA1. Mutations in human OPA1 cause optic atrophy, but the molecular basis for membrane fusion and pathogenesis is not clear. Here, we determined the crystal structure of the minimal GTPase domain (MGD) of human OPA1. A three-helix bundle (HB) domain including two helices extending from the GTPase (G) domain and the last helix of OPA1 tightly associates with the G domain. In the presence of GDP and BeF3-, OPA1-MGD forms a dimer, the interface of which is critical for the maintenance of mitochondrial morphology. The catalytic core of OPA1 possesses unique features that are not present in other dynamin-like proteins. Biochemical experiments revealed that OPA1-MGD forms nucleotide-dependent dimers, which is important for membrane-stimulated GTP hydrolysis, and an N-terminal extension mediates nucleotide-independent dimerization that facilitates efficient membrane association. Our results suggest a multifaceted assembly of OPA1 and explain the effect of most OPA1 mutations on optic atrophy.

Identifiants

pubmed: 32379273
pii: 151743
doi: 10.1083/jcb.201907098
pmc: PMC7337494
pii:
doi:

Substances chimiques

Liposomes 0
Recombinant Proteins 0
Guanosine Diphosphate 146-91-8
beryllium fluoride 499FU9DQ5C
GTP Phosphohydrolases EC 3.6.1.-
OPA1 protein, human EC 3.6.1.-
Magnesium I38ZP9992A
Beryllium OW5102UV6N
Fluorides Q80VPU408O
Potassium RWP5GA015D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020 Yu et al.

Références

Hum Mol Genet. 2007 Jun 1;16(11):1307-18
pubmed: 17428816
J Cell Biol. 2016 Dec 5;215(5):621-629
pubmed: 27920125
Hum Mol Genet. 2010 Jun 1;19(11):2113-22
pubmed: 20185555
Cell. 2006 Oct 20;127(2):383-95
pubmed: 17055438
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
Nat Genet. 2000 Oct;26(2):211-5
pubmed: 11017080
Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15927-32
pubmed: 15509649
Nat Genet. 2000 Oct;26(2):207-10
pubmed: 11017079
Trends Cell Biol. 2019 Mar;29(3):257-273
pubmed: 30527453
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Cell Rep. 2017 Jun 20;19(12):2557-2571
pubmed: 28636943
Mol Biol Cell. 2009 Aug;20(15):3525-32
pubmed: 19477917
Nat Cell Biol. 2017 Jul;19(7):856-863
pubmed: 28628083
Nature. 2010 May 27;465(7297):435-40
pubmed: 20428113
J Cell Sci. 2016 Jun 15;129(12):2297-306
pubmed: 27189080
Nat Struct Mol Biol. 2018 Mar;25(3):233-243
pubmed: 29483649
EMBO J. 2018 May 15;37(10):
pubmed: 29632021
Cell. 2011 Sep 30;147(1):209-22
pubmed: 21962517
J Cell Biol. 2007 Aug 27;178(5):749-55
pubmed: 17709429
Nature. 2017 Feb 16;542(7641):372-376
pubmed: 28114303
Biochim Biophys Acta Bioenerg. 2018 Apr;1859(4):263-269
pubmed: 29382469
Antioxid Redox Signal. 2013 Aug 1;19(4):379-88
pubmed: 23350575
Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3496-3514
pubmed: 30293569
Mol Biol Cell. 2011 Jul 1;22(13):2235-45
pubmed: 21551073
Biochim Biophys Acta. 2013 Jan;1833(1):176-83
pubmed: 22902477
Nature. 2019 Jul;571(7765):429-433
pubmed: 31292547
J Cell Physiol. 2007 May;211(2):423-30
pubmed: 17167772
Cell Death Differ. 2007 Apr;14(4):682-92
pubmed: 17024226
Brain. 2015 Jan;138(Pt 1):e321
pubmed: 25146916
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4061-4070
pubmed: 32041880
Nat Rev Mol Cell Biol. 2010 Dec;11(12):872-84
pubmed: 21102612
Semin Cell Dev Biol. 2016 Dec;60:105-111
pubmed: 27269373
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
EMBO J. 2006 Jul 12;25(13):2966-77
pubmed: 16778770
Biochim Biophys Acta. 2009 Jan;1793(1):20-6
pubmed: 18691613

Auteurs

Caiting Yu (C)

College of Life Sciences and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
School of Medicine, Tsinghua University, Beijing, China.

Jinghua Zhao (J)

College of Life Sciences and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Liming Yan (L)

School of Medicine, Tsinghua University, Beijing, China.

Yuanbo Qi (Y)

College of Life Sciences and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Xiangyang Guo (X)

College of Life Sciences and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Zhiyong Lou (Z)

School of Medicine, Tsinghua University, Beijing, China.

Junjie Hu (J)

College of Life Sciences and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.

Zihe Rao (Z)

College of Life Sciences and State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
School of Medicine, Tsinghua University, Beijing, China.
National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH